Send mail to Author

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. Oncological outcomes after a median 15-year follow-up (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __   _    _     _____     ______    _  __     ___    
 | |/ // | || | ||  /  ___||  /_   _//  | |/ //   / _ \\  
 | ' //  | || | || | // __     -| ||-   | ' //   | / \ || 
 | . \\  | \\_/ || | \\_\ ||   _| ||_   | . \\   | \_/ || 
 |_|\_\\  \____//   \____//   /_____//  |_|\_\\   \___//  
 `-` --`   `---`     `---`    `-----`   `-` --`   `---`   
                                                          
 


Back to frontdoor view